Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Linical Co., Ltd. ( (JP:2183) ) has provided an update.
Linical Co., Ltd. reported a significant decline in its financial performance for the fiscal year ending March 31, 2025, with net sales dropping by 15.2% and a net loss of ¥539 million. Despite the downturn, the company forecasts a recovery in the next fiscal year with an expected 7.3% increase in net sales and a return to profitability.
More about Linical Co., Ltd.
Linical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the clinical research industry. It focuses on providing services related to drug development and clinical trials, catering to the pharmaceutical and biotechnology sectors.
Average Trading Volume: 50,056
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.71B
See more data about 2183 stock on TipRanks’ Stock Analysis page.